Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Lorbrena (lorlatinib) for ALK-Positive Metastatic Non-Small Cell Lung Cancer

Lorbrena® is available as a once a day tablet in 0.25mg and 100mg strengths. Credit: Adam Rhoades.

  • Lorbrena
  • Lorbrena
  • Lorbrena

Go Top